Network Bio

🗓 Founded 2022👥 24 employees💰 Last funded Oct 2024
Network Bio builds AI for medicine on the worlds largest patient tissue training dataset, linked to blood samples and clinical outcomes from top US academic biobanks. We’re backed by top-tier investors S32, Thiel Bio, Founders Fund, Blue Venture Fund, and Breyer Capital.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Network Bio?
Network Bio has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Network Bio last raise funding?
The most recent investment in Network Bio recorded on gritt.io was in October 2024.
When was Network Bio founded?
Network Bio was founded in 2022.
What industry is Network Bio in?
Network Bio operates in Artificial Intelligence. Find similar Artificial Intelligence investors on gritt.io.